Why is Jenburkt Pharma falling/rising?

As of 29-Oct, Jenburkt Pharmaceuticals Ltd. is experiencing a price increase, currently at 1,151.70, reflecting a rise of 85.35 or 8.0%. The stock opened with a gain of 4.19% today and reached an intraday high of Rs 1175, marking a 10.19% increase. Over the past week, the stock has outperformed its sector by 7.26%. In terms of returns, the stock has shown a 1-week increase of 8.13%, a 1-month increase of 5.96%, and a 1-year increase of 16.92%. However, it is important to note that the year-to-date return is down by 5.19%. Despite the positive movement today, there has been a decline in investor participation, with delivery volume falling by 41.53% against the 5-day average, indicating some caution among investors.
Broader Market Context: The Sensex, as a benchmark, has shown a modest increase of 0.68% over the past week, which suggests that Jenburkt Pharmaceuticals is significantly outperforming the broader market in the short term. While the stock has had a strong performance recently, its year-to-date decline contrasts with the Sensex's gain of 8.78%, highlighting a potential recovery phase for the stock. The stock's liquidity remains adequate for trading, but the lower delivery volume could signal a need for cautious optimism among investors. Overall, the recent price movement reflects a combination of positive short-term performance and underlying concerns regarding investor engagement.